Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-03-15

Clinical Trial Update: Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating olopatadine hydrochloride ophthalmic solution in seasonal allergic rhinitis using an OHIO chamber, with results posted in 2010…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION (olopatadine hydrochloride ophthalmic solution)

Snippet

Sponsor: Alcon Research | Conditions: Allergic Conjunctivitis | Phase 4 | Status: COMPLETED | Results posted: 2010-03-15